I went in with an open mind but I should have done my due diligence more carefully. Firstly they went public last November, I saw a lot of positive reviews at the same time posted within a day or two of each other, CLEARLY an inside PR stunt. This company is losing money, with a operating net yearly loss of more than $10 million, strictly relying on stock funds to survive. They are not approved in the states by the FDA now or for the foreseeable future. Then I discovered all of them come from cardiac science, which is clearly another sign to stay away from this “insider” job and club, ...."beware" is the key word.